Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yacht Bio-Technology is a Taiwan-based biotechnology company specializing in the development of exosome-based therapeutics and regenerative medicine. The company utilizes its proprietary Exo-X platform to isolate and engineer high-purity exosomes derived from mesenchymal stem cells (MSCs). Their research focuses on applications in dermatology, hair restoration, and orthopedic conditions such as osteoarthritis. By leveraging cell-free technology, Yacht Bio-Technology aims to provide safer and more stable alternatives to traditional stem cell therapies for clinical and aesthetic use. The company maintains GMP-compliant facilities to ensure the quality and scalability of its exosome production for both research and commercial applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yacht Bio-Technology.